TP53 and neoplasm: The results of a French study based on 61 individuals with or without germline mutations in TP53 from 41 families with LFS confirmed that MDM2 polymorphism had an impact on the age of tumor on set, this effect may be amplified by Pro72Arg polymorphism and the differences between the groups also showed a cumulative effect of these two polymorphisms [71].